Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardised laxative therapy for opioid-induced constipation in adults receiving around-the-clock opioid therapy
2013-000180-81Phase 4Completed
- Sponsor
- Mundipharma Research
- Start
- Apr 2013
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sennoside B and docusate sodium in opioid-induced constipation (OIC), sponsored by Mundipharma Research. Primary endpoints: Effect of standardised laxative therapy for reversal of opioid-induced constipation and Tolerability of standardised laxative therapy. Started Apr 2013; status: completed.
02
Drugs
sennoside Bdocusate sodium
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2013-000180-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000180-81.